Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Bryan Marlen Reasons
Age : 52
Public asset : 414,741 USD
Linked companies : Aclaris Therapeutics, Inc. - Recro Pharma, Inc. - Mallinckrodt plc
Summary 
Bryan Marlen Reasons holds the position of Chief Financial Officer & Executive Vice President at Mallinckrodt Plc and Chairman for Impax Laboratories (Taiwan), Inc. Mr. Reasons is also on the board of Aclaris Therapeutics, Inc., Recro Pharma, Inc. and MKG Medical UK Ltd.

He previously occupied the position of Chief Financial Officer & Senior Vice President for Amneal Pharmaceuticals, Inc. Chief Financial Officer & Vice President-Finance at Impax Laboratories LLC and Senior Manager at Impax Laboratories LLC (both are subsidiaries of Amneal Pharmaceuticals, Inc.), Vice President-Finance of Teva Pharmaceutical Industries Ltd. and Vice President-Finance for Cephalon, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.) and Senior Manager at PricewaterhouseCoopers LLP.

Bryan Marlen Reasons received an MBA from Widener University and an undergraduate degree from The Pennsylvania State University.


Current positions of Bryan Marlen Reasons 
NameTitle Since
Aclaris Therapeutics, Inc.
(Biotechnology & Medical Research)
Independent Director 2018
Recro Pharma, Inc.
(Pharmaceuticals)
Independent Director 2017
Mallinckrodt plc
(Pharmaceuticals)
Chief Financial Officer & Executive Vice President 2019
Impax Laboratories (Taiwan), Inc. Chairman -
MKG Medical UK Ltd. Director 2020


Holdings of Bryan Marlen Reasons 
NameEquities%Valuation
Aclaris Therapeutics, Inc. (ACRS)
(Biotechnology & Medical Research)
16,2090.026%281,226 USD
Recro Pharma, Inc. (REPH)
(Pharmaceuticals)
67,4290.14%131,487 USD
Mallinckrodt plc (MNKKQ)
(Pharmaceuticals)
11,5930.014%2,029 USD


Bryan Marlen Reasons: Personal Network 
Most Read News 
11/23ELON MUSK : Tesla's Musk exercises more options, sells shares worth $1.05 billion
RE
12/05MUKESH AMBANI : Indian salesmen threaten supply disruptions in protest against Reliance
RE
11/30JACK DORSEY : Jack Dorsey chases crypto, fintech dream post Twitter
RE
11/24JAMIE DIMON : Jamie Dimon jokes that JPMorgan will outlast China's Communist Party
RE
12/01JACK DORSEY : Dorsey-led Square rebrands to Block in nod to blockchain
RE
12/07ELON MUSK : Tesla's Musk says Biden's electric vehicle bill should not pass Congress
RE
12/03CATHIE WOOD : Cathie Wood's ARK Innovation fund hits 13-month low in tech selloff
RE
11/26ELON MUSK : Tesla decides against state aid for German battery plant as Musk opposes subsidies
RE
12/02ELON MUSK : Musk exercises more options, sells Tesla shares worth $1.01 billion
RE
11/30Salesforce shares fall on disappointing profit forecast
RE
More news


© 2021 People and Ownership :   
Bryan Marlen Reasons : Connections